Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
![Foto de Centro de Investigación de Medicina Aplicada (CIMA)](/img/uploaded/775F334D27340F135DFC5AC46D7B50CB.jpg)
![Foto de Emory University School of Medicine](/img/noimage_org.png)
Emory University School of Medicine
Atlanta, Estados UnidosPublicaciones en colaboración con investigadores/as de Emory University School of Medicine (10)
2024
-
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
The Lancet Oncology, Vol. 25, Núm. 5, pp. e205-e216
2023
-
Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
Blood cancer discovery, Vol. 4, Núm. 5, pp. 365-373
2021
-
Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation
Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321
-
Minimal residual disease in Myeloma: Application for clinical care and new drug registration
Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212
2020
-
DNA methylation and body mass index from birth to adolescence: meta-analyses of epigenome-wide association studies
Genome Medicine, Vol. 12, Núm. 1
-
Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
Open Heart, Vol. 7, Núm. 1
2019
-
Epigenome-wide meta-analysis of DNA methylation and childhood asthma
Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 6, pp. 2062-2074
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
-
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology, Vol. 17, Núm. 8, pp. e328-e346
2014
-
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
The Lancet Oncology, Vol. 15, Núm. 12, pp. e538-e548